Published in Am J Surg Pathol on April 01, 2014
Potential clinical implications of BRAF mutations in histiocytic proliferations. Oncotarget (2014) 1.07
Pulmonary Langerhans Cell Histiocytosis with Lytic Bone Involvement in an Adult Smoker: Regression following Smoking Cessation. Case Rep Hematol (2015) 0.78
Physiologic Determinants of Exercise Capacity in Pulmonary Langerhans Cell Histiocytosis: A Multidimensional Analysis. PLoS One (2017) 0.75
Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma. Am J Surg Pathol (2015) 0.75
Clinicopathological features and BRAF(V600E) mutations in patients with isolated hypothalamic-pituitary Langerhans cell histiocytosis. Diagn Pathol (2016) 0.75
Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations. Mod Pathol (2017) 0.75
Adult Langerhans cell histiocytosis with pulmonary and colorectoanal involvement: a case report. J Med Case Rep (2017) 0.75
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation. Oncotarget (2016) 0.75
[Pulmonary Langerhans cell histiocytosis]. Pathologe (2015) 0.75
Molecular analysis of BRAF V600E mutation in multiple nodules of pulmonary Langerhans cell histiocytosis. Virchows Arch (2017) 0.75
Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol (2017) 0.75
Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases. Virchows Arch (2017) 0.75
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med (2013) 6.82
Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 6.71
Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway. Kidney Int (2009) 3.12
C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up. Kidney Int (2012) 3.05
Etiology of chylothorax in 203 patients. Mayo Clin Proc (2005) 2.98
Septic pulmonary embolism: presenting features and clinical course of 14 patients. Chest (2005) 2.97
Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas. Hum Pathol (2009) 2.64
MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol. Oncogene (2004) 2.62
Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest (2005) 2.60
Spontaneous pneumomediastinum: analysis of 62 consecutive adult patients. Mayo Clin Proc (2009) 2.55
A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med (2012) 2.54
Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease. Chest (2007) 2.34
Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 2.32
Yellow nail syndrome: analysis of 41 consecutive patients. Chest (2008) 2.30
Pulmonary necrotizing granulomas of unknown cause: clinical and pathologic analysis of 131 patients with completely resected nodules. Chest (2013) 2.21
Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest (2009) 2.16
Pulmonary cryptococcosis in nonimmunocompromised patients. Chest (2003) 2.16
Frequency of mediastinal lymphadenopathy in patients with idiopathic pulmonary arterial hypertension. Chest (2013) 2.01
Hot tub lung: presenting features and clinical course of 21 patients. Respir Med (2005) 1.89
Pulmonary involvement in Henoch-Schönlein purpura. Mayo Clin Proc (2004) 1.83
Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med (2002) 1.81
Reducing iatrogenic risk in thoracentesis: establishing best practice via experiential training in a zero-risk environment. Chest (2008) 1.79
The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis. Kidney Int (2013) 1.79
Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. Am J Respir Crit Care Med (2002) 1.78
Motion corrected cadence CPS ultrasound for quantifying response to vasoactive drugs in a rat kidney model. Urology (2009) 1.78
Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2003) 1.77
Chronic nitrofurantoin-induced lung disease. Mayo Clin Proc (2005) 1.76
Cigarette smoke-induced mitochondrial fragmentation and dysfunction in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2014) 1.72
Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol (2009) 1.68
Immunoglobulin derived depositions in the nervous system: novel mass spectrometry application for protein characterization in formalin-fixed tissues. Lab Invest (2008) 1.67
Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum (2010) 1.67
Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci U S A (2013) 1.66
Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Invest Radiol (2011) 1.64
Medullary amyloidosis associated with apolipoprotein A-IV deposition. Kidney Int (2011) 1.56
Interstitial lung disease in primary Sjögren syndrome. Chest (2006) 1.55
Proteomic typing of amyloid deposits in systemic amyloidoses. Amyloid (2011) 1.55
Pulmonary langerhans cell histiocytosis. Orphanet J Rare Dis (2012) 1.54
Worse disease-free survival in never-smokers with ALK+ lung adenocarcinoma. J Thorac Oncol (2012) 1.51
Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States. Blood (2014) 1.50
Are respiratory complications common causes of death in inflammatory myopathies? An autopsy study. Respirology (2012) 1.48
Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer. Mol Pharmacol (2005) 1.47
Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int (2012) 1.45
Sonographically guided thoracentesis and rate of pneumothorax. J Clin Ultrasound (2005) 1.44
Interferon gamma-1b therapy for advanced idiopathic pulmonary fibrosis. Mayo Clin Proc (2003) 1.43
Yellow nail syndrome. Curr Opin Pulm Med (2009) 1.43
Pleural fluid characteristics of chylothorax. Mayo Clin Proc (2009) 1.39
Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest (2005) 1.38
Familial idiopathic pulmonary fibrosis: clinical features and outcome. Chest (2005) 1.34
Cystic lung disease in Birt-Hogg-Dube syndrome. Chest (2007) 1.34
Lung disease in rheumatoid arthritis. Curr Opin Rheumatol (2008) 1.33
Pulmonary cryptococcosis: CT findings in immunocompetent patients. Radiology (2005) 1.32
Are inositol pyrophosphates signalling molecules? J Cell Physiol (2009) 1.31
TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms. Mod Pathol (2009) 1.30
Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. Chest (2006) 1.29
Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways. J Immunol (2008) 1.29
Lung cryobiopsies: a paradigm shift in diagnostic bronchoscopy? Respirology (2014) 1.27
Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin. N Engl J Med (2012) 1.26
Asthma-related environmental fungus, Alternaria, activates dendritic cells and produces potent Th2 adjuvant activity. J Immunol (2009) 1.26
Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. Carcinogenesis (2006) 1.25
Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. Chest (2004) 1.24
C3 glomerulonephritis associated with monoclonal gammopathy: a case series. Am J Kidney Dis (2013) 1.24
TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol (2004) 1.24
Cough-induced rib fractures. Mayo Clin Proc (2005) 1.23
Pneumocystis carinii cell wall beta-glucans initiate macrophage inflammatory responses through NF-kappaB activation. J Biol Chem (2003) 1.21
Pulmonary Langerhans' cell histiocytosis. Clin Chest Med (2004) 1.21
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis. Thorax (2012) 1.21
Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma. Mol Ther (2012) 1.20
Diagnosis of interstitial lung diseases. Mayo Clin Proc (2007) 1.19
Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control study. PLoS One (2011) 1.19
Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol (2013) 1.19
Chronic obstructive pulmonary disease after myocardial infarction in the community. Am Heart J (2010) 1.19
Tracheobronchial adenoid cystic carcinoma: a clinicopathologic study of 14 cases. Chest (2004) 1.18
N-terminal truncation of antiapoptotic MCL1, but not G2/M-induced phosphorylation, is associated with stabilization and abundant expression in tumor cells. J Biol Chem (2007) 1.17
Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest (2004) 1.17
Improving the safety of thoracentesis. Curr Opin Pulm Med (2011) 1.16
Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells. Carcinogenesis (2006) 1.14
Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism. J Immunol (2006) 1.13
Noninvasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using computer-aided nodule assessment and risk yield (CANARY)--a pilot study. J Thorac Oncol (2013) 1.13
Histopathologic Overlap between Fibrosing Mediastinitis and IgG4-Related Disease. Int J Rheumatol (2012) 1.12
The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis. Chest (2005) 1.11
Exacerbation of pre-existing interstitial lung disease after oxaliplatin therapy: a report of three cases. Respir Med (2007) 1.11
IgG4-related paratesticular pseudotumor in a patient with autoimmune pancreatitis and retroperitoneal fibrosis: an extrapancreatic manifestation of IgG4-related disease. Hum Pathol (2012) 1.11
Thymic stromal lymphopoietin in cigarette smoke-exposed human airway smooth muscle. J Immunol (2010) 1.10
Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Clin J Am Soc Nephrol (2010) 1.10
A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer. Cancer Res (2011) 1.10
Donor-acceptor conjugated polymer based on naphtho[1,2-c:5,6-c]bis[1,2,5]thiadiazole for high-performance polymer solar cells. J Am Chem Soc (2011) 1.08
Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium study. Respir Res (2010) 1.07
Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest (2005) 1.06
Spectrum of Disorders Associated with Elevated Serum IgG4 Levels Encountered in Clinical Practice. Int J Rheumatol (2012) 1.06